Millennium Management LLC cut its position in shares of Auna SA (NYSE:AUNA – Free Report) by 71.4% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 29,291 shares of the company’s stock after selling 73,178 shares during the quarter. Millennium Management LLC’s holdings in Auna were worth $201,000 at the end of the most recent quarter.
Wall Street Analysts Forecast Growth
Several equities analysts recently issued reports on AUNA shares. Hsbc Global Res raised shares of Auna to a “hold” rating in a research note on Thursday, May 22nd. Wall Street Zen upgraded Auna from a “hold” rating to a “buy” rating in a report on Friday, June 6th. Finally, HSBC set a $7.90 price target on Auna and gave the stock a “hold” rating in a research note on Thursday, May 22nd.
Read Our Latest Research Report on Auna
Auna Stock Up 1.3%
Auna (NYSE:AUNA – Get Free Report) last issued its earnings results on Tuesday, May 20th. The company reported $0.19 earnings per share for the quarter, beating analysts’ consensus estimates of $0.16 by $0.03. The firm had revenue of $281.43 million during the quarter, compared to analyst estimates of $1.12 billion. During the same quarter in the previous year, the business posted $0.10 EPS. On average, research analysts expect that Auna SA will post 0.5 earnings per share for the current year.
Auna Company Profile
Auna SA, a healthcare service provider, operates hospitals and clinics in Mexico, Peru, and Colombia. The company provides prepaid healthcare plans in Peru; and dental and vision plans in Mexico. The company was founded in 1989 and is based in Luxembourg, Luxembourg.
Read More
- Five stocks we like better than Auna
- High Dividend REITs: Are They an Ideal Way to Diversify?
- Ignore the Noise—Samsara Stock Is Still a Strong Buy
- How to trade using analyst ratings
- 3 Stocks Set to Double—And There’s Still Time to Buy
- Utilities Stocks Explained – How and Why to Invest in Utilities
- Analysts Can’t Get Enough of These Little-Known Biopharma Stocks
Receive News & Ratings for Auna Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Auna and related companies with MarketBeat.com's FREE daily email newsletter.